{
  "id": "NCLEX_NGN_SA_500171",
  "itemType": "standalone",
  "questionType": "selectN",
  "caseId": null,
  "question": {
    "stem": "The nurse is reviewing the client's electronic health record (EHR) before administering the 0900 (9:00 AM) medications. Based on the data provided, which actions are **essential** for the nurse to take at this time? Select all that apply.",
    "tabs": [
      {
        "id": "tab1",
        "label": "Nurses' Notes",
        "content": "0730 (07:30): Client is a 48-year-old male with a history of alcohol use disorder, currently experiencing homelessness. Brought to the emergency department by paramedics after being found down on a sidewalk for an unknown duration. Client is drowsy but oriented to person and place. GCS 14 (E4 V4 M6). Complains of severe, diffuse muscle pain, especially in the thighs and lower back. Skin is cool and clammy. Indwelling urinary catheter placed, draining scant, dark brown urine."
      },
      {
        "id": "tab2",
        "label": "Vital Signs",
        "content": [
          {
            "time": "0745 (07:45)",
            "BP": "102/68 mmHg",
            "HR": "118 bpm",
            "RR": "22/min",
            "Temp": "37.1째C (98.8째F)",
            "SpO2": "95% on room air"
          },
          {
            "time": "0845 (08:45)",
            "BP": "94/60 mmHg",
            "HR": "126 bpm",
            "RR": "24/min",
            "Temp": "37.2째C (99.0째F)",
            "SpO2": "94% on room air"
          }
        ]
      },
      {
        "id": "tab3",
        "label": "Laboratory Results",
        "content": [
          {
            "test": "Potassium (K+)",
            "value": "6.8 mEq/L",
            "range": "3.5-5.0 mEq/L"
          },
          {
            "test": "Sodium (Na+)",
            "value": "132 mEq/L",
            "range": "136-145 mEq/L"
          },
          {
            "test": "BUN",
            "value": "92 mg/dL",
            "range": "10-20 mg/dL"
          },
          {
            "test": "Creatinine (Cr)",
            "value": "5.4 mg/dL",
            "range": "0.6-1.2 mg/dL"
          },
          {
            "test": "Creatine Kinase (CK)",
            "value": "65,200 U/L",
            "range": "30-220 U/L"
          },
          {
            "test": "Troponin I",
            "value": "0.09 ng/mL",
            "range": "<0.04 ng/mL"
          },
          {
            "test": "Lactate",
            "value": "3.2 mmol/L",
            "range": "0.5-2.2 mmol/L"
          }
        ]
      },
      {
        "id": "tab4",
        "label": "Diagnostics",
        "content": "12-Lead ECG Interpretation: Sinus tachycardia at 125 bpm. Peaked T-waves. QRS duration 0.14 seconds. No acute ST elevation or depression noted."
      },
      {
        "id": "tab5",
        "label": "Medication Administration Record (MAR)",
        "content": [
          {
            "medication": "0.9% Sodium Chloride",
            "dose": "150 mL/hr continuous IV infusion"
          },
          {
            "medication": "Calcium Gluconate 1 gram IV",
            "dose": "Administer STAT, over 5 minutes"
          },
          {
            "medication": "Spironolactone",
            "dose": "25 mg PO",
            "frequency": "Daily at 0900 (09:00)"
          },
          {
            "medication": "Lisinopril",
            "dose": "10 mg PO",
            "frequency": "Daily at 0900 (09:00)"
          }
        ]
      }
    ],
    "options": [
      {
        "id": "opt1",
        "text": "Hold the scheduled dose of spironolactone."
      },
      {
        "id": "opt2",
        "text": "Initiate a rapid 1 L bolus of 0.9% sodium chloride."
      },
      {
        "id": "opt3",
        "text": "Administer the STAT dose of IV calcium gluconate."
      },
      {
        "id": "opt4",
        "text": "Hold the scheduled dose of lisinopril."
      },
      {
        "id": "opt5",
        "text": "Request a cardiology consult for the elevated troponin."
      },
      {
        "id": "opt6",
        "text": "Prepare to administer sodium polystyrene sulfonate."
      }
    ]
  },
  "answer": {
    "correct": [
      "opt1",
      "opt3",
      "opt4"
    ],
    "answerBreakdown": [
      {
        "optionId": "opt1",
        "isCorrect": true,
        "rationale": "Correct. The client's potassium level is critically elevated at 6.8 mEq/L, indicating severe hyperkalemia. Spironolactone is a potassium-sparing diuretic, which inhibits sodium reabsorption in the distal tubules, leading to increased potassium retention. Administering spironolactone would exacerbate the hyperkalemia, potentially leading to life-threatening cardiac arrhythmias. This is a critical 'SAFETY STOP' action.",
        "clinicalPearl": "Always assess potassium levels before administering potassium-sparing diuretics. Hyperkalemia can cause fatal cardiac arrhythmias.",
        "highlight": []
      },
      {
        "optionId": "opt2",
        "isCorrect": false,
        "rationale": "Incorrect. While fluid resuscitation with 0.9% sodium chloride is indicated for rhabdomyolysis and acute kidney injury (AKI) to promote renal perfusion and flush out myoglobin, the immediate priority is addressing the life-threatening hyperkalemia and its cardiac effects. The ECG changes (peaked T-waves, widened QRS) indicate imminent risk of cardiac arrest. Addressing the hyperkalemia takes precedence. Also, changing an infusion rate to a bolus requires a provider's order.",
        "clinicalPearl": "In hyperkalemia with ECG changes, prioritize cardiac stabilization before aggressive fluid resuscitation. Monitor for fluid overload during resuscitation.",
        "highlight": []
      },
      {
        "optionId": "opt3",
        "isCorrect": true,
        "rationale": "Correct. The client has severe hyperkalemia (6.8 mEq/L) with ECG evidence of cardiotoxicity (peaked T-waves, widened QRS). IV calcium gluconate is the first-line, emergent treatment to stabilize the cardiac membrane by raising the threshold potential, making the myocardium less excitable and preventing fatal dysrhythmias. Calcium gluconate does not lower potassium levels but antagonizes its effects on the heart. This is the highest priority 'PROCEED' action.",
        "clinicalPearl": "Calcium gluconate is a cardiac membrane stabilizer used in hyperkalemia to prevent arrhythmias. It does not lower potassium levels. Monitor ECG during administration.",
        "highlight": []
      },
      {
        "optionId": "opt4",
        "isCorrect": true,
        "rationale": "Correct. Lisinopril, an ACE inhibitor, can cause or exacerbate hyperkalemia by inhibiting the production of angiotensin II, which leads to decreased aldosterone secretion. Aldosterone normally promotes potassium excretion. Additionally, lisinopril is contraindicated in hemodynamically unstable clients with AKI due to the risk of further reducing renal perfusion. The client's hypotension and elevated creatinine indicate AKI. Administering lisinopril is unsafe and could worsen both hyperkalemia and AKI. This is another critical 'SAFETY STOP' action.",
        "clinicalPearl": "ACE inhibitors and ARBs can worsen hyperkalemia, especially in patients with kidney injury or those taking potassium-sparing diuretics. Monitor potassium and renal function closely.",
        "highlight": []
      },
      {
        "optionId": "opt5",
        "isCorrect": false,
        "rationale": "Incorrect. The mildly elevated troponin (0.09 ng/mL) is likely secondary to the massive skeletal muscle breakdown (rhabdomyolysis) or demand ischemia from shock, not a primary acute coronary syndrome (ACS). Rhabdomyolysis releases troponin from damaged muscle cells. The life-threatening priority is managing the severe hyperkalemia and its cardiac effects. While a cardiology consult may be warranted later, it is not the immediate priority. This action distracts from the immediate 'KILLER' problem.",
        "clinicalPearl": "Elevated troponin in the setting of rhabdomyolysis can be due to skeletal muscle damage and does not always indicate myocardial infarction. Consider CK-MB and clinical context.",
        "highlight": []
      },
      {
        "optionId": "opt6",
        "isCorrect": false,
        "rationale": "Incorrect. Sodium polystyrene sulfonate (Kayexalate) is a treatment for hyperkalemia, but it acts slowly by exchanging sodium for potassium in the gut, leading to potassium excretion in the feces. It is not an emergent intervention for severe hyperkalemia with ECG changes. The priority is immediate cardiac stabilization with calcium gluconate. Kayexalate also carries a risk of intestinal necrosis, especially in patients with bowel dysfunction.",
        "clinicalPearl": "Sodium polystyrene sulfonate (Kayexalate) is not a first-line treatment for acute, severe hyperkalemia due to its slow onset of action and risk of intestinal necrosis.",
        "highlight": []
      }
    ],
    "scoring": {
      "type": "plusMinus",
      "points": 1
    }
  },
  "metadata": {
    "difficulty": "Hard",
    "level": 5,
    "topic": "Acute Kidney Injury (AKI)",
    "missionSeed": "MISSION-500-171-1771352262941",
    "nclexClientNeed": "Physiological Integrity: Reduction of Risk Potential",
    "cognitiveSkill": "Take Actions",
    "ngnSkill": "Recognize Cues, Analyze Cues, Prioritize Hypotheses, Take Actions"
  },
  "scenario": {
    "SBAR": {
      "Situation": "The nurse is preparing to administer medications to a 48-year-old male client at 0900 (09:00). The client has a history of alcohol use disorder and is currently experiencing homelessness. He was brought to the emergency department after being found on a sidewalk.",
      "Background": "The client is drowsy, oriented to person and place, with a GCS of 14. He complains of severe muscle pain, especially in the thighs and lower back. His skin is cool and clammy. An indwelling urinary catheter is in place, draining scant, dark brown urine. Vital signs show hypotension (94/60 mmHg) and tachycardia (126 bpm). Laboratory results indicate hyperkalemia (6.8 mEq/L), hyponatremia (132 mEq/L), elevated BUN (92 mg/dL) and creatinine (5.4 mg/dL), significantly elevated creatine kinase (65,200 U/L), mildly elevated troponin (0.09 ng/mL), and elevated lactate (3.2 mmol/L). ECG shows sinus tachycardia with peaked T-waves and widened QRS.",
      "Assessment": "The client is exhibiting signs and symptoms of rhabdomyolysis and acute kidney injury (AKI) secondary to prolonged immobilization and possible dehydration. The most critical finding is severe hyperkalemia with evidence of cardiotoxicity, indicated by peaked T-waves and widened QRS complex on the ECG.",
      "Recommendation": "The nurse should immediately administer calcium gluconate 1 gram IV STAT over 5 minutes to stabilize the cardiac membrane. Hold the scheduled doses of spironolactone 25 mg PO and lisinopril 10 mg PO at 0900 (09:00). Continuously monitor vital signs, ECG, and laboratory values, particularly potassium levels. Anticipate further interventions, such as fluid resuscitation with 0.9% sodium chloride and management of AKI, as directed by the provider. Prepare for possible dialysis if hyperkalemia is refractory to medical management."
    }
  },
  "sentinelStatus": "healed_v2026_v8"
}